Trials / Completed
CompletedNCT05570357
Berberine and Cinnamon in Management of Diabetes
The Effects of Berberine and Cinnamon Supplementation on Diabetes Mangement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In this randomized clinical trial, patients with diabetes will be randomly assigned to receive either Berberine, and Cinnamon supplements or placebo for 12 weeks. Then the glycemic characteristics will be compared in two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Berberine+Cinnamon (TDS) | The supplements contains 400 mg Berberine, and 200 mg Cinnamon extract |
| OTHER | Placebo (TDS) | Placebo contains Maltodexterin |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-01-01
- Completion
- 2023-02-10
- First posted
- 2022-10-06
- Last updated
- 2024-06-11
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT05570357. Inclusion in this directory is not an endorsement.